TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Capital expenditures 2013–2022
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$548.0MFY2022 · since FY2013: $1.0B → $548.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $548.0M | -2.5% |
| FY2021 | $562.0M | -2.8% |
| FY2020 | $578.0M | +10.1% |
| FY2019 | $525.0M | -19.4% |
| FY2018 | $651.0M | -25.5% |
| FY2017 | $874.0M | -3.0% |
| FY2016 | $901.0M | +16.7% |
| FY2015 | $772.0M | -16.9% |
| FY2014 | $929.0M | -9.9% |
| FY2013 | $1.0B | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice